Akeso has now been advised to submit a sNDA to Chinese regulators for cadonilimab’s approval in gastric cancer by an ...

The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...

Nutritional support enhances treatment continuity in malnourished patients with advanced gastric cancer and independently ...

A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted therapies like claudin 18.2-directed therapy. Biomarker testing is essential ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

Clinicians can help reduce gastric cancer incidence and mortality in high-risk groups through endoscopic screening and surveillance of precancerous conditions, such as gastric intestinal metaplasia ...

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

In many regions, doctors practice in settings with limited medical resources. Advanced tests, specialist support, and expert ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its high prevalence, it has received far less molecular attention than colorectal ...

Scientists have found a link between blood type A and a higher risk of stomach cancer. This connection appears over time.